MarketCap
Facebook
X
Telegram
Danaher Corporation Market Cap | DHR
As of September 14, 2026 Danaher Corporation has a market cap of $ 144 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 150 B | 152 B | 183 B | 181 B | 196 B | 155 B | 121 B | 76.4 B | 70.7 B | 55.5 B | 45.9 B | 43.9 B | 39.7 B | 31.5 B | 26.9 B |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 196 B | 26.9 B | 102 B |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
4.03 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
Anixa Biosciences
ANIX
|
104 K | $ 2.81 | 1.81 % | $ 91.2 K | USA |
|
Biodesix
BDSX
|
113 M | $ 27.16 | 0.7 % | $ 205 M | USA |
 |
Heska Corporation
HSKA
|
844 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Syneos Health
SYNH
|
9.41 B | - | - | $ 4.46 B | USA |
 |
Meridian Bioscience
VIVO
|
1.38 B | - | - | $ 1.49 B | USA |
 |
Motus GI Holdings
MOTS
|
990 K | - | -34.28 % | $ 263 K |  Israel |
 |
Renalytix AI plc
RNLX
|
22.7 M | - | 5.66 % | $ 22.7 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Psychemedics Corporation
PMD
|
16.8 M | - | -1.84 % | $ 15.3 M | USA |
 |
Quotient Limited
QTNT
|
237 M | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
T2 Biosystems
TTOO
|
7.78 M | - | -39.35 % | $ 313 K | USA |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
Biomerica
BMRA
|
6.09 M | $ 2.28 | 1.79 % | $ 6.65 M | USA |
 |
BioNano Genomics
BNGO
|
7.95 M | $ 1.34 | 9.81 % | $ 7.3 M | USA |
 |
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 11.75 | 5.68 % | $ 124 M |  China |
 |
Bioventus
BVS
|
608 M | $ 13.21 | 1.77 % | $ 880 M | USA |
 |
CareDx, Inc
CDNA
|
993 M | $ 52.06 | 3.58 % | $ 2.77 B | USA |
 |
Celcuity
CELC
|
5.37 B | $ 83.18 | 0.07 % | $ 3.89 B | USA |
 |
Co-Diagnostics
CODX
|
5.85 M | $ 1.14 | 1.83 % | $ 1.52 M | USA |
 |
Charles River Laboratories International
CRL
|
7.69 B | $ 269.68 | 0.06 % | $ 13.4 B | USA |
 |
Castle Biosciences
CSTL
|
472 M | $ 32.99 | 2.04 % | $ 956 M | USA |
 |
Quest Diagnostics Incorporated
DGX
|
23.3 B | $ 237.41 | 1.06 % | $ 26.4 B | USA |
 |
DarioHealth Corp.
DRIO
|
32.8 M | $ 7.1 | 2.45 % | $ 28.3 M | Israel |
 |
Brainsway Ltd.
BWAY
|
301 M | $ 13.66 | 0.14 % | $ 464 M | Israel |
 |
DexCom
DXCM
|
25.5 B | $ 84.28 | 1.5 % | $ 32.9 B | USA |
 |
Fulgent Genetics
FLGT
|
527 M | $ 20.51 | 0.29 % | $ 631 M | USA |
 |
Guardant Health
GH
|
13.4 B | $ 163.86 | 4.11 % | $ 20.5 B | USA |
 |
ICON Public Limited Company
ICLR
|
10.1 B | $ 169.16 | 0.97 % | $ 13.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
51.1 B | $ 507.97 | 0.65 % | $ 40.9 B | USA |
 |
Illumina
ILMN
|
25.3 B | $ 208.08 | 0.79 % | $ 32.3 B | USA |
 |
IQVIA Holdings
IQV
|
28.3 B | $ 264.32 | 0.98 % | $ 45.4 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
23.9 B | $ 311.9 | 0.1 % | $ 26 B | USA |
 |
Lantheus Holdings
LNTH
|
5.12 B | $ 100.28 | 0.02 % | $ 6.77 B | USA |
 |
Medpace Holdings
MEDP
|
13 B | $ 591.59 | 0.69 % | $ 17.1 B | USA |
 |
Mettler-Toledo International
MTD
|
28.4 B | $ 1 287.29 | 1.01 % | $ 26.5 B | Schweiz |
 |
Myriad Genetics
MYGN
|
409 M | $ 3.66 | 7.02 % | $ 339 M | USA |
 |
ENDRA Life Sciences
NDRA
|
3.66 M | $ 5.68 | 0.98 % | $ 4.47 M | USA |
 |
NeoGenomics
NEO
|
1.48 B | $ 17.9 | 3.35 % | $ 2.29 B | USA |
 |
Neogen Corporation
NEOG
|
2.51 B | $ 11.86 | 0.64 % | $ 2.58 B | USA |
 |
National Research Corporation
NRC
|
315 M | $ 22.12 | 4.71 % | $ 495 M | USA |
 |
Natera
NTRA
|
30.5 B | $ 336.64 | 2.34 % | $ 46 B | USA |
 |
OPKO Health
OPK
|
1.04 B | $ 1.56 | 0.38 % | $ 1.17 B | USA |
 |
Pacific Biosciences of California
PACB
|
498 M | $ 1.36 | 4.23 % | $ 408 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.3 B | $ 25.17 | 2.28 % | $ 23.9 B |  Niderland |
 |
Personalis
PSNL
|
431 M | $ 16.33 | 0.74 % | $ 1.46 B | USA |